Global Single-use Bioprocessing System Market 2017-2021

SKU ID :TNV-10610964 | Published Date: 26-Apr-2017 | No. of pages: 70
Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by application • Market overview • mAB production • Vaccine production • Plant cell cultivation • PSCTs • Others PART 07: Market segmentation by product type • Market overview • Bags and mixers • Bioreactors and fermenters • Filtration devices and sampling systems • Bioprocess containers • Tubing systems (connectors/pipes) • Others PART 08: Market segmentation by end-users • Market overview • Pharmaceutical companies • CROs & CMOs • Biotechnology companies • Academic and research institutions PART 09: Geographical segmentation • Market overview • Americas • EMEA • APAC PART 10: Decision framework PART 11: Drivers and challenges • Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments PART 12: Market trends • Increasing adoption of single-use bioprocessing in pre-clinical and commercial stage • Emergence of downstream disposables • SUT aiding continuous bioprocessing PART 13: Vendor landscape • Competitive scenario PART 14: Key vendor analysis • Danaher • GE Healthcare • Merck • Sartorius • Thermo Fisher Scientific • Other prominent vendors PART 15: Appendix • List of abbreviations Exhibit 01: Advantages of single-use technologies over stainless steel technology Exhibit 02: Global single-use bioprocessing systems market ($ billions) Exhibit 03: Ongoing trends in biopharmaceutical industry impacting the adoption of single-use technologies Exhibit 04: Five forces analysis Exhibit 05: Global single-use bioprocessing systems market by application 2016-2021 (%) Exhibit 06: Global single-use bioprocessing systems market for mAB production 2016-2021 ($ millions) Exhibit 07: Global single-use bioprocessing systems market for vaccine production 2016-2021 ($ millions) Exhibit 08: Global single-use bioprocessing systems market for plant cell cultivation 2016-2021 ($ millions) Exhibit 09: Global single-use bioprocessing systems market for PSCTs 2016-2021 ($ millions) Exhibit 10: Global single-use bioprocessing systems market for other applications 2016-2021 ($ millions) Exhibit 11: Global single-use bioprocessing systems market by product type 2016-2021 (%) Exhibit 12: Global single-use bags and mixers market 2016-2021 ($ millions) Exhibit 13: Global SUBs and fermenters market 2016-2021 ($ millions) Exhibit 14: Global single-use filtration devices and sampling systems market 2016-2021 ($ millions) Exhibit 15: Global single-use bioprocess containers market 2016-2021 ($ millions) Exhibit 16: Global single-use tubing systems market 2016-2021 ($ millions) Exhibit 17: Global single-use others market 2016-2021 ($ millions) Exhibit 18: Global single-use bioprocessing systems market by end-users 2016 and 2021 Exhibit 19: Pharmaceutical companies in global single-use bioprocessing systems market 2016-2021 ($ millions) Exhibit 20: CROs and CMOs in global single-use bioprocessing systems market 2016-2021 ($ millions) Exhibit 21: Biotech companies in global single-use bioprocessing systems market 2016-2021 ($ millions) Exhibit 22: Academic and research institutions in global single-use bioprocessing systems market 2016-2021 ($ millions) Exhibit 23: Global single-use bioprocessing systems market by geography 2016-2021 Exhibit 24: Single-use bioprocessing systems market in Americas 2016-2021 ($ billions) Exhibit 25: Single-use bioprocessing systems market in EMEA 2016-2021 ($ billions) Exhibit 26: Single-use bioprocessing systems market in APAC 2016-2021 ($ billions) Exhibit 27: Recent M&As in the single-use bioprocessing systems market Exhibit 28: Impact of drivers Exhibit 29: Impact of challenges Exhibit 30: Advantages of implementing single-use bioprocessing systems Exhibit 31: Strategic success factor of consideration for companies Exhibit 32: Danaher: Profile Exhibit 33: Danaher: Strength analysis Exhibit 34: Danaher: Strategy assessment Exhibit 35: Danaher: Opportunity assessment Exhibit 36: GE Healthcare: Profile Exhibit 37: GE Healthcare: Strength analysis Exhibit 38: GE Healthcare: Strategy assessment Exhibit 39: GE Healthcare: Opportunity assessment Exhibit 40: Merck: Profile Exhibit 41: Merck: Strength analysis Exhibit 42: Merck: Strategy assessment Exhibit 43: Merck: Opportunity assessment Exhibit 44: Sartorius: Profile Exhibit 45: Sartorius: Strength analysis Exhibit 46: Sartorius: Strategy assessment Exhibit 47: Sartorius: Opportunity assessment Exhibit 48: Thermo Fisher Scientific: Profile Exhibit 49: Thermo Fisher Scientific: Strength analysis Exhibit 50: Thermo Fisher Scientific: Strategy assessment Exhibit 51: Thermo Fisher Scientific: Opportunity assessment
Danaher, GE Healthcare, Merck, Sartorius, Thermo Fisher Scientific, Broadley-James Corporation, Eppendorf, and Saint-Gobain.
  • PRICE
  • $2500
    $4000

Our Clients